• 1
    Wallace DJ, Podell TE, Weiner JM, Cox MB, Klinenberg JR, Forouzesh S, Dubois EL: Lupus nephritis: experience with 230 patients in a private practice from 1950 to 1980. Am J Med 72: 209220, 1982
  • 2
    Austin III HA, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, Decker JL, Balow JE: Prognostic factors in lupus nephritis: contribution of renal histologic data. Am J Med 75: 382391, 1983
  • 3
    Austin III HA, Muenz LR, Joyce KM, Antonovych TT, Balow JE: Diffuse proliferative nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 25: 689695, 1984
  • 4
    Banfi G, Mazzucco G, Di Belgiojoso GB, Bosisio MB, Stratta P, Confalonieri R, Ferrario F, Imbasciati E, Monga G: Morphological parameters in lupus nephritis: their relevance for classification and relationship with clinical and histological findings and outcome. Q J Med 55: 153168, 1985
  • 5
    Stamenkovic I, Favre H, Donath A, Assimacopoulos A, Chatelanat F: Renal biopsy in SLE irrespective of clinical findings: long-term follow-up. Clin Nephrol 26: 109115, 1986
  • 6
    Appel GB, Cohen DJ, Pirani CL, Meltzer JI, Estes D: Long-term follow-up of patients with lupus nephritis: a study based on the classification of the World Health Organization. Am J Med 83: 877885, 1987
  • 7
    Magill AB, Puterman ML, Ballon HS, Chan V, Lirenman DS, Rae A, Sutton RAL: Prognostic factors in diffuse proliferative lupus glomerulonephritis. Kidney Int 34: 511517, 1988
  • 8
    Esdaile JM, Levinton C, Federgreen W, Hayslett JP, Kashgarian M: The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of patients and review of the literature. Q J Med 72: 779833, 1989
  • 9
    Schwartz MM, Bernstein J, Hill GS, Holley K, Phillips EA, the Lupus Nephritis Collaborative Study Group: Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Kidney Int 39: 891896, 1989
  • 10
    Laitman RS, Glicklich D, Sablay LB, Grayzel AI, Barland P, Bank N: Effect of long-term normalization of serum complement levels on the course of lupus nephritis. Am J Med 87: 132138, 1989
  • 11
    Nossent HC, Henzen-Logmans SC, Vroom TM, Berden JHM, Swaak TJG: Contribution of renal biopsy data in predicting outcome in lupus nephritis: analysis of 116 patients. Arthritis Rheum 33: 970977, 1990
  • 12
    McLaughlin J, Gladman DD, Urowitz MB, Bombardier C, Farewell VT, Cole E: Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy results. Arthritis Rheum 34: 12681273, 1991
  • 13
    Levey AS, Lan S-P, Corwin HD, Kasinath BS, Lachin J, Neilson EG, Hunsicker LG, Lewis EJ, and the Lupus Nephritis Collaborative Study Group: Progression and remission of renal disease in the lupus nephritis collaborative study: results of treatment with prednisone and short-term oral cyclophosphamide. Ann Intern Med 116: 114123, 1992
  • 14
    McCurdy DK, Lehman TJA, Bernstein B, Hanson V, King KK, Nadorra R, Landing BH: Lupus nephritis: prognostic factors in children. Pediatrics 89: 240246, 1992
  • 15
    Esdaile JM, MacKenzie T, Barré P, Danoff D, Osterland CK, Somerville P, Quintal H, Kashgarian M, Suissa S: Can experienced clinicians predict the outcome of lupus nephritis? Lupus 1: 205214, 1992
  • 16
    Derksen RHWM, Hené RJ, Kater L: The long-term clinical outcome of 56 patients with biopsy-proven lupus nephritis followed at a single center. Lupus 1: 97103, 1992
  • 17
    Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL): Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Am J Kidney Dis 19: 473479, 1992
  • 18
    Goulet JR, MacKenzie T, Levinton C, Hayslett JP, Ciampi A, Esdaile JM: The long-term prognosis of lupus nephritis: the impact of disease activity. J Rheumatol 20: 5965, 1993
  • 19
    Fraenkel L, MacKenzie T, Joseph L, Kashgarian M, Hayslett JP, Esdaile JM: Response to therapy as a predictor of outcome in lupus nephritis (abstract). Arthritis Rheum 35 (suppl 9): S180, 1992
  • 20
    McMahon B: The national death index. Am J Public Health 73: 647648, 1983
  • 21
    WilkinsonRG (ed). Class and Health: Research and Longitudinal Data. New York, Tavistock Publications, 1986
  • 22
    Urowitz MB, Gladman DD, Tozman ECS, Goldsmith CH: The lupus activity criteria count. J Rheumatol 11: 783787, 1984
  • 23
    Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, the Committee on Prognosis Studies in SLE: Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 35: 630640, 1992
  • 24
    LeRiche NGH, Muenz LR, Silverman JA, Decker JL: Development of an SLE activity index. Submitted for publication
  • 25
    Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, Wasner C, Medsger TA Jr, Ziegler G, Klippel JH, Hadler NM, Albert DA, Hess EV, Spencer-Green G, Grayzel A, Worth D, Hahn BH, Barnett EV: A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 25: 601611, 1982
  • 26
    Kaplan MH, Feinstein AR: The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 27: 387404, 1974
  • 27
    Cox DR: Regression models and life tables (with discussion). J R Stat Soc B 34: 187220, 1972
  • 28
    Ramsay J: Monotone splines in action (with discussion). Stat Sci 3: 425461, 1988
  • 29
    Ramsay JO, Abrahamowicz M: Binomial regression with monotone splines: a psychometric application. J Am Stat Assoc 84: 906915, 1989
  • 30
    Sleeper LA, Harrington DP: Regression splines in the Cox model with application to covariate effects in liver disease. J Am Stat Assoc 85: 941949, 1990
  • 31
    Abrahamowicz M, Ciampi A, Ramsay JO: Non-parametric density estimation for censored survival data: regression splines approach. Can J Stat 20: 171185, 1992
  • 32
    Akaike H: A new look at the statistical model identification. IEEE Trans Automatic Control AC 19: 716723, 1974
  • 33
    Esdaile JM, Federgreen W, Quintal H, Suissa S, Hayslett JP, Kashgarian M: Predictors of one year outcome in lupus nephritis: the importance of renal biopsy. Q J Med 81: 907918, 1991
  • 34
    Schwartz MM, Fennell JS, Lewis EJ: Pathologic changes in the renal tubule in systemic lupus erythematosus. Hum Pathol 13: 534547, 1982
  • 35
    Park MH, Agati VD, Appel GB, Pirani CL: Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. Nephron 44: 309319, 1986
  • 36
    Alexopoulos E, Seron D, Hartley RB, Cameron JS: Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 37: 100109, 1990
  • 37
    Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Kidney Int 20: 117, 1992
  • 38
    Petri M, Spence D, Bone LR, Hochberg MC: Coronary artery disease risk factors in the Johns Hopkins lupus cohort: prevalence, recognition by patients and preventative practices. Medicine (Baltimore) 71: 291302, 1992
  • 39
    Esdaile JM, Joseph L, MacKenzie T, Kashgarian M, Hayslett JP: The pathogenesis and prognosis of lupus nephritis: information from repeat renal biopsy. Semin Arthritis Rheum 23: 135148, 1993
  • 40
    Tokano Y, Yasuma M, Harada S, Takasaki Y, Hashimoto H, Okuria K, Hirose S: Clinical significance of anti-Sm and U1, RNP antibodies in patients with systemic lupus erythematosus and mixed connective tissue disease. J Clin Immunol 11: 317325, 1991